It is likely that the levels of TP53I13 expression may vary in tumor and paracancerous groups; hence, we explored this conjecture by analyzing DElncRNAs, DEmRNAs, and DEmiRNAs in glioma samples. The gene discussed is TP53I13; the disease is neoplasm.